Latest Breaking News On - Lainate - Page 8 : comparemela.com

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

Giro d'Italia Stage 21 LIVE

Senago - Milano 30.3 km Timetrial Well, we have reached the end of the via, only a TT remains. Let's see if it can create some excitement but a lot seems decided. We can guess who wins, it's.

Cassiopea announces results of AGM 2021

Cassiopea announces results of AGM 2021 Search jobs Cassiopea S.p.A. / Key word(s): Miscellaneous 29-Apr-2021 / 18:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Pierpaolo Guzzo is following on Jan de Vries as Chairman Lainate - April 29, 2021 - Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, announced the results of its Annual General Meeting held today on April 29, 2021 in Lainate, Milan (Italy). Owing to the COVID-19 health emergency and in compliance with art. 106 of Law Decree n. 18 dated March 17, 2020, converted into Law n. 27 dated April 24, 2020 (as last amended by Law-Decree n. 183 dated December 20, 2020, converted with amendments into Law n. 21 dated February 26, 2021) aimed at minimizing travel

Lists of candidates for the board of directors at the AGM 2021

Lists of candidates for the board of directors at the AGM 2021 Cassiopea S.p.A. / Key word(s): Miscellaneous 21-Apr-2021 / 07:01 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Lainate - April 21, 2021 - Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, today announced the lists of candidates proposed for the board of directors at the Annual General Meeting of 29 April 2021, in Lainate, Milan (Italy). The list proposed by Cassiopea s shareholder Cosmo Pharmaceuticals NV consists of the following candidates: Pierpaolo Guzzo (incumbent, executive), Jan de Vries (incumbent, non-executive, independent), Diana Harbort (incumbent, executive) and Oyvind Bjordal (incumbent, non-executive, independent

Cassiopea Reports Year End 2020 Results